Tocqueville Asset Management L.P. Iovance Biotherapeutics, Inc. Transaction History

Tocqueville Asset Management L.P.

$6.27 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$6.38 - $18.33 $1.09 Million - $3.14 Million	-171,290 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $375,733 - $579,685	30,350 Added 21.53%	171,290 $2.85 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $139,020 - $232,092	-8,400 Reduced 5.62%	140,940 $2.69 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $259,462 - $339,532	-12,750 Reduced 7.87%	149,340 $3.68 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $1.12 Million - $2.27 Million	68,500 Added 73.19%	162,090 $4.22 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $53,326 - $97,817	-1,860 Reduced 1.95%	93,590 $2.96 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $1.7 Million - $3.04 Million	60,450 Added 172.71%	95,450 $4.43 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $488,500 - $971,250	-25,000 Reduced 41.67%	35,000 $1.05 Million
Q4 2019 Jan 14, 2020	SELL	$17.95 - $29.41 $1.23 Million - $2.02 Million	-68,605 Reduced 53.35%	60,000 $1.66 Million
Q3 2019 Oct 31, 2019	BUY	$17.99 - $26.0 $27,884 - $40,300	1,550 Added 1.22%	128,605 $2.34 Million
Q2 2019 Jul 31, 2019	BUY	$9.78 - $24.52 $811,055 - $2.03 Million	82,930 Added 187.94%	127,055 $3.12 Million
Q1 2019 Apr 30, 2019	BUY	$8.41 - $11.26 $145,493 - $194,798	17,300 Added 64.49%	44,125 $420,000
Q4 2018 Feb 08, 2019	BUY	$7.51 - $11.93 $22,530 - $35,790	3,000 Added 12.59%	26,825 $237,000
Q3 2018 Nov 13, 2018	SELL	$11.25 - $17.7 $12,375 - $19,470	-1,100 Reduced 4.41%	23,825 $268,000
Q2 2018 Aug 13, 2018	BUY	$12.45 - $16.95 $175,545 - $238,995	14,100 Added 130.25%	24,925 $319,000
Q1 2018 May 14, 2018	BUY	$8.1 - $19.5 $87,682 - $211,087	10,825 New	10,825 $183,000

Others Institutions Holding IOVA

# of Institutions

312

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.01B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account